DetailsChartProfileRisk matrixNewsDocuments

MAGELLAN I/  FR0011238344  /

Fonds
NAV2024-07-30 Chg.-0.0300 Type of yield Investment Focus Investment company
20.7500EUR -0.14% reinvestment Equity Emerging Markets Comgest ▶
GlobeNewswire 06-28 Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
GlobeNewswire 06-28 Michael Braham appointed CareSource Military & Veterans president
GlobeNewswire 06-27 Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
GlobeNewswire 06-27 Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) For...
GlobeNewswire 06-25 Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire 06-14 Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
GlobeNewswire 06-13 Gain Therapeutics Announces Proposed Public Offering
GlobeNewswire 06-13 Giant Magellan Telescope Enclosure Ready for Construction
GlobeNewswire 05-30 Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federati...
GlobeNewswire 05-14 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 05-14 Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire 04-24 Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire 04-08 Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...
GlobeNewswire 04-01 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 03-27 Cegedim Full year 2023 results: Revenue and recurring operating income both up
GlobeNewswire 03-26 Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
GlobeNewswire 03-15 Gain Therapeutics to Present at Public Ventures Discovery Day
GlobeNewswire 03-05 Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action ...
GlobeNewswire 03-05 Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
GlobeNewswire 02-27 Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 ...
GlobeNewswire 02-20 Diamondback Energy, Inc. Announces Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire 02-20 Giant Magellan Telescope Expands Global Science Impact with Taiwanese Partner
GlobeNewswire 02-14 Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight
GlobeNewswire 02-13 Navios Maritime Partners L.P. Reports Financial Results for the Fourth Quarter and Year Ended Decemb...
GlobeNewswire 02-06 UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson...